Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Point72 Asset Management increased stake in Bicycle Therapeutics plc

Published 10/02/2020, 06:15 PM
Updated 10/02/2020, 06:30 PM
© Reuters.  Point72 Asset Management increased stake in Bicycle Therapeutics plc

© Reuters. Point72 Asset Management increased stake in Bicycle Therapeutics plc

On the 14th of September, Point72 Asset Management added 702 thousand Bicycle Therapeutics plc (NASDAQ:BCYC) shares for $13 million at an average price of $19.08 per share. Shares of Bicycle Therapeutics plc are up 2.20% since the transaction.

Point72 Asset Management's holding in Bicycle Therapeutics plc increased to about 1.1 million shares with the purchase.

Point72 Asset Management first bought Bicycle Therapeutics plc stock in the fourth quarter of 2019. Point72 Asset Management also owns Merck (MRK), MacroGenics, Inc. (NASDAQ:MGNX), PTC Therapeutics, Inc. (NASDAQ:PTCT) and uniQure N.V. (NASDAQ:QURE). Bicycle Therapeutics plc is its number fourteen position by number of shares and market value among biotechnology & life sciences stocks.

Other investors who also added to their Bicycle Therapeutics plc shares include Millennium Management. In contrast, Victory Capital Management and Squarepoint Ops reduced BCYC shares.

Point72 Asset Management has also recently increased their share in MacroGenics, Inc. The total value of the shares bought is estimated at around $67 million.

Point72 Asset Management also established new holdings in ANGI Homeservices Inc. (NASDAQ:ANGI), Dave & Busters Entertainment Inc (PLAY) and Fulcrum Therapeutics, Inc. (NASDAQ:FULC). Point72 Asset Management also increased their share in American Eagle Outfitters Inc (NYSE:AEO), The Children's Place, Inc. (NASDAQ:PLCE), Otonomy, Inc. (NASDAQ:OTIC) and Revolve Group , Inc. (NYSE:RVLV). The total value of the shares bought is estimated at around $254 million.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.